- Home
- CAC vs ARCT Comparison
CAC vs ARCT Comparison
Compare CAC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- ARCT
- Stock Information
- Founded
- CAC 1875
- ARCT 2013
- Country
- CAC United States
- ARCT United States
- Employees
- CAC N/A
- ARCT N/A
- Industry
- CAC Major Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- ARCT Health Care
- Exchange
- CAC Nasdaq
- ARCT Nasdaq
- Market Cap
- CAC N/A
- ARCT 298.3M
- IPO Year
- CAC 1997
- ARCT N/A
- Fundamental
- Price
- CAC $43.34
- ARCT $13.78
- Analyst Decision
- CAC Hold
- ARCT Strong Buy
- Analyst Count
- CAC 3
- ARCT 8
- Target Price
- CAC $47.33
- ARCT $52.83
- AVG Volume (30 Days)
- CAC 56.5K
- ARCT 484.1K
- Earning Date
- CAC 07-29-2025
- ARCT 08-04-2025
- Dividend Yield
- CAC 3.88%
- ARCT N/A
- EPS Growth
- CAC 2.54
- ARCT N/A
- EPS
- CAC 3.09
- ARCT N/A
- Revenue
- CAC $184,324,000.00
- ARCT $143,680,000.00
- Revenue This Year
- CAC $40.83
- ARCT N/A
- Revenue Next Year
- CAC $5.29
- ARCT $34.79
- P/E Ratio
- CAC $14.04
- ARCT N/A
- Revenue Growth
- CAC 13.26
- ARCT 15.38
- 52 Week Low
- CAC $31.79
- ARCT $8.04
- 52 Week High
- CAC $50.07
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- CAC 71.29
- ARCT 58.14
- Support Level
- CAC $38.11
- ARCT $12.65
- Resistance Level
- CAC $40.92
- ARCT $14.09
- Average True Range (ATR)
- CAC 0.99
- ARCT 0.94
- MACD
- CAC 0.44
- ARCT 0.05
- Stochastic Oscillator
- CAC 99.26
- ARCT 64.60
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.